Like other incretin-based therapies, it requires a stepwise titration protocol to balance effectiveness with safety, particularly gastrointestinal side effects that tend to appear at higher doses
big pharma and large telehealth marketplaces cant build huge margins around it, so you rarely see splashy campaigns
This association suggests that the metabolic benefits of metformin extend to the protection of dopaminergic neurons
Regarding oral contraceptives specifically, a clinically relevant interaction with delayed gastric emptying has been documented for tirzepatide in its UK Summary of Product Characteristics (SmPC), which advises the use of a non-oral or additional contraceptive method during initiation and dose escalation
And at some point, I mean, size matters
Given semaglutides advantages, when might Saxenda still make sense